Jonathan Steckbeck

Jonathan Steckbeck is the Founder, President, and CEO of Peptilogics, a clinical-stage biotechnology company specializing in peptides, orthopedics, and anti-infectives. Since September 2013, Jonathan has been instrumental in advancing the company's innovative core intellectual property, successfully raising $66 million in funding from notable investors including Peter Thiel and Founders Fund. Additionally, Jonathan serves on the board of Life Sciences Pennsylvania since May 2022. Jonathan holds a PhD in Biochemistry from the University of Pittsburgh School of Medicine, an MBA from the University of Pittsburgh Katz Graduate School of Business, and a B.S. in Microbiology from Penn State University.